English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [709]
News [2443]
Articles [199]
Editorials [6]
Conferences [89]
elearning [31]
New biomarkers unlock potential for more effective treatment of deadly cancers
New biomarkers unlock potential for more effective treatment of deadly cancers
Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID-19 vaccination
Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID...
Listeria-based booster improves vaccine’s protection against recurring colon cancer
Listeria-based booster improves vaccine’s protection against recurring colon cancer
Study highlights undiscovered potential of bacterial compounds and genes linked to colon cancer-related toxin
Study highlights undiscovered potential of bacterial compounds and genes linked to colon cancer-related toxin
ASCO 2022: Gut microbiome associated with increased immune cell infiltration in the tumour microenvironment and response to immunotherapy across cancer types
ASCO 2022: Gut microbiome associated with increased immune cell infiltration in the tumour microenvironment and...
Screening and removal of precancerous lesions prevents anal cancer
Screening and removal of precancerous lesions prevents anal cancer
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
How diet and the microbiome affect colorectal cancer
How diet and the microbiome affect colorectal cancer
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic colorectal cancer
ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic colorectal cancer
<1...5152535455...245>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top